冠状与年龄相关的血管变化:病理生理学和成像研究的新见解
Zhe Sun1,2, Chenyang Li1, Dominique Leitner3
1Department of Radiology, NYU Grossman School of Medicine, New York, NY, USA.
Aging and disease
|September 3, 2025
概括
老化膜 (ChP) 显示血管和结构变化影响大脑液体和免疫功能. 这些变化与阿尔茨海默氏症等神经退行性疾病有关,
科学领域:
- 神经科学
- 血管生物学
- 老龄化研究
背景情况:
- 冠状腺 (ChP) 产生脑脊液 (CSF),但其血管和结构变化未得到充分研究.
- 这些变化可能会扰乱脑液平衡,免疫调节和废物清除,导致神经退行.
- 它是血液和脑液之间的关键接口,
研究的目的:
- 审查与年龄相关的血管和结构变化.
- 探索这些变化对脑液动态,免疫功能和血液-脑液屏障 (BCSFB) 的影响
- 讨论神经退行性疾病的影响,并确定未来的研究方向.
主要方法:
- 对CHP衰老的细胞病理分析.
- 神经成像技术,包括体积MRI和高分辨率对比增强MRI.
- 在痴呆症,特别是阿尔茨海默病 (AD) 中进行蛋白质组学研究.
主要成果:
- 由于衰老变化,ChP通常会扩大,而不是缩小.
- 组织学显示上皮退化, 厚化的底层膜, 和纤维化.
- 阿尔茨海默病的蛋白质组显示了与免疫相关的蛋白质以及与脑脊液清除相关的蛋白质的改变.
结论:
- 与年龄相关的CHP血管和结构变化显著影响大脑平衡和BCSFB完整性.
- 这些变化与AD,PD,NPH和ALS等神经退行性疾病的发病有关.
- 进一步研究CHP衰老对于开发神经疾病的诊断和治疗策略至关重要.
更多相关视频
相关概念视频
The Effect of Aging on Tissues
3.6K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.6K
Pharmacodynamics in Geriatric Patients: Effects of Age
376
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
376
Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Coronary Artery Disease III: Clinical Manifestations
627
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
627
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
773
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
773
Imaging Studies VII: Vascular Imaging
568
DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
568


